Snowball logo
logo
ACAD_logo

ACADIA Pharmaceuticals Inc

ACAD β€’ NASDAQ
$30.58+$0.93Β  (3.14%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
484.1517.2726.4957.81,071.51,138.6
COGS
19.1410.1745.7381.8489101
Gross Profit
465507.1680.7876982.51,037.7
Operating Expenses & Income
Operating Income
(170.4)(223.6)(73.38)230.8104.886.37
Total Operating Expenses
635.4730.7754.1645.2877.7951.3
R&D Expenses
239.4361.6351.6303.2328.8331
Selling General & Admin Expenses
396369.1393.1488.4548.9620.3
Earnings from Continuing Operations
Interest Expense
(6.264)(6.61)----
Interest Income
0.5916.6117.2325.4631.7232.62
Income Tax Expense
0.3512.53110.2531.62(252.1)(259.1)
Net Income
Net Income
(167.9)(216)(61.29)226.5391380.5
Supplemental
EBIT
(170.4)(223.6)(51.04)84.28138.9104.1
EBITDA
(167.1)(221.6)(45.48)100.2150.7116.1
In millions of USD, except % and values per 1 share